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 Abstract 
  Aims:   The study aimed to compare the frequency of neuropsychiatric symptoms (NPS) across 
the declining memory continuum, from normal aging, subjective cognitive impairment (SCI), 
and mild cognitive impairment (MCI) to Alzheimer’s disease (AD), and to explore the clinical cor-
relates of NPS.   Method:   In a memory clinic, 157 subjects (46 mild AD patients, 38 MCI individu-
als, 24 SCI subjects, and 49 normal controls) completed the neurobehavioral assessments with 
the Neuropsychiatric Inventory (NPI). The clinical significance of each NPI domain was defined 
as an item score  6 4.  Result:  Clinically significant depression was more common in the SCI than 
in the normal control group (p  !  0.05). The frequency of NPS was significantly greater in the mild 
AD group compared to other groups. Clinically significant apathy and aberrant motor behavior 
were more common among the AD group than the MCI group (p   !   0.05). The MMSE score (OR 
4.84, 95% CI 1.92–12.16, p = 0.001) and apathy (OR 12.73, 95% CI 1.48–109.68, p = 0.021) signifi-
cantly determined the diagnostic status as MCI or mild AD.   Conclusion:   Across the declining 
memory continuum, the frequency of NPS was highest among mild AD patients. Depression, 
apathy, and aberrant motor behavior deserve more attention. Presence of apathy might be an 
independent determinant for mild AD.    Copyright © 2012 S. Karger AG, Basel 
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 Background 
  For patients with dementia, the presence of neuropsychiatric symptoms (NPS) usually 
results in institutionalization, placement in nursing homes, increased utilization of medical 
resources, more caregiver stress, diminished quality of life for the persons with dementia and 
their families, and greater economic burden on the caregivers   [1]  . A preliminary survey in 
China had demonstrated that economic burden of dementia was significantly correlated 
with the presence of NPS   [2]  .
    Over the disease course of dementia, 80–90% of patients with dementia experienced 
NPS   [3]  . In the Cardiovascular Health Study, 75% of dementia patients exhibited NPS, 62% 
were rated as clinically significant, and the most common disturbances were apathy, depres-
sion, and agitation   [4]  . A research conducted in nursing homes and neurology outpatient 
departments in the northern part of Taiwan showed that 100% of dementia patients had at 
least one NPS. The most common NPS in order of decreasing frequency were nighttime be-
havior, apathy, aberrant motor behavior (AMB), and depression among dementia patients. 
In the outpatient department, nighttime behavior, apathy, AMB, euphoria, and depression 
were common   [5]  .
  Mild cognitive impairment (MCI) has emerged as an identifiable condition and, in many 
cases, a likely state preceding diagnosable Alzheimer’s disease (AD)   [6]  . There is an annual 
conversion rate of 10–15% from amnesic-type MCI to AD   [7, 8]  . NPS were common in MCI: 
43% of MCI participants exhibited NPS, 29% were rated as clinically significant, depression, 
apathy, and irritability being the most common   [4]  . In a systematic review, it was found that 
the prevalence rate of NPS in MCI ranged from 35 to 85%. Depression, anxiety, and irritabil-
ity were most common. NPS, particularly depression, might represent risk factors for MCI 
or predictors for the conversion of MCI to AD   [9]  .
  Subjective cognitive impairment (SCI) is also called subjective memory complaints. Some 
researchers found that SCI was common in old people. The prevalence varied from 22 to 50%. 
SCI was associated with aging, female gender, low level of education, depression, and lower 
MMSE scores  [10, 11] . SCI was a stage prior to MCI in the eventual development of AD demen-
tia  [12] . Reisberg et al.  [13]  found that (1) there was support from at least one longitudinal study 
for a long-standing concept of SCI as a pre-MCI condition lasting approximately 15 years; (2) 
there were complex relationships between SCI and depression and anxiety; (3) differences be-
tween SCI subjects and age-matched non-SCI persons were being published in terms of cogni-
tive tests, hippocampal gray matter density, hippocampal volumes, cerebral metabolism, and 
urinary cortisol levels. It was one of the few reports about the NPS of SCI to date.
    Although there have been many reports on NPS of MCI and dementia, currently, few 
studies compare these disturbances across the declining memory continuum, from normal 
cognition, SCI, and MCI to AD. Therefore, we tested the hypothesis that, as cognitive impair-
ment progresses from normal cognition, SCI, and MCI to AD, the prevalence of NPS would 
increase. In addition, we also proposed to explore the clinical correlates of NPS among indi-
viduals with MCI and mild AD.
  M e t h o d s  
  All subjects who had completed the neuropsychological and neurobehavioral assess-
ments were retrieved from the database of the Dementia Care and Research Center, Peking 
University Institute of Mental Health, from March, 2006, to March, 2010. A total of 157 sub-
jects (46 mild AD patients, 38 MCI individuals, 24 SCI subjects, and 49 normal controls, NC) 
were included in this analysis.202
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  Inclusion  Criteria 
 The diagnosis of AD was made according to NINCDS-ADRDA criteria  [14] . Individu-
als with MCI met Petersen criteria including (1) memory complaint (preferably corrobo-
rated by a caregiver); (2) normal activities of daily living; (3) normal general cognitive func-
tion; (4) abnormal memory on cognitive testing (generally performance  6 1.5 SD below age 
and education-adjusted scores), and (5) the absence of dementia (clinical judgment)  [6] . SCI 
was defined by the presence of memory complaints   6  6 months, normal objective memo-
ry performance, and normal activities of daily living. NC was defined by absence of mem-
ory complaints, normal objective memory performance, and normal activities of daily liv-
ing   [15] .
  I n s t r u m e n t s  
  The Neuropsychiatric Inventory (NPI) was the major instrument for the assessment of 
NPS  [16] . The Chinese version of the NPI has been validated in Chinese communities  [17, 18]  
and was used in this study to assess NPS, including domains of delusions, hallucinations, 
agitation/aggression, depression/dysphoria, anxiety, euphoria/elation, apathy/indifference, 
disinhibition, irritability/lability, AMB, nighttime behavior disturbance, and changes in ap-
petite and eating behavior. Severity and frequency of these domains were evaluated based on 
an interview with an informant, primarily family members, by a trained rater. The score of 
each domain was calculated by multiplying the frequency score by the severity score, and the 
sum of 12 domain scores constituted the total NPI score. Presence of individual NPS was 
defined as the domain score   1  0. The presence of clinically significant NPS was defined as 
the domain score   6 4.
    The Chinese version of the Mini-Mental State Examination (MMSE) was used to assess 
the general cognitive function of all subjects   [19]  . Mild AD was defined as having a total 
MMSE score   1 2 0    [2 0] .
  A n a l y s i s  
  Statistical analysis was performed with the Statistical Package for Social Sciences, ver-
sion 16 (SPSS Inc., Chicago, Ill., USA). The frequency of clinically significant NPS among the 
four groups was compared with the Kruskal-Wallis H test. A 2   !   2 crosstabulation     2   test 
was used for comparisons of categorical data between the two groups. For the 2   !   2 cross-
tabulation     2   test, Fisher’s exact test was deployed if there were one or more cell(s) having an 
expected count   !  5. Statistical significance was set at a p value   ! 0.05  throughout.
    The association between scores of each NPS domain and cognitive assessment scores 
(i.e., MMSE) was assessed by partial correlation while controlling for age and educational 
levels. To identify the effects of cognitive function and presence of clinically significant NPS 
on determining subject status, i.e., AD, MCI, and cognitively normal, the Hosmer-Lemeshow 
test was first deployed and found that the variables were fit for logistic regression analysis for 
AD against MCI or cognitively normal groups. Hence, multivariate logistic regression anal-
yses were conducted. Age, educational level, gender, and MMSE score were included through-
out the analyses. For each analysis, only clinically significant NPS bearing statistical signif-
icance between the two groups were included. Age, education, and MMSE score were in-
c l u d e d  a s  c o n t i n u o u s  v a r i a b l e s ,  a n d  g e n d e r  a n d  p r e s e n c e  o f  N P S  w e r e  c o n s i d e r e d  a s  
categorical variables. The reference category was female, and presence of clinically signifi-
cant NPS. The variables to determine the status of MCI against normal cognition were not 
fit for logistic regression analysis; the multivariate discriminant analysis, specifically with 
Wilks’      stepwise method and leave-one-out classification was introduced. Throughout the 
multivariate regression analysis and discriminant analysis, variables were entered with the 
probability of F   !   0.05 and were removed at p   1   0.10.203
Dement Geriatr Cogn Disord Extra 2012;2:200–208
 DOI:  10.1159/000338410 
  Published online: April 27, 2012 
EXTRA
  Zhang et al.: Prevalence of NPS across the Declining Memory Continuum 
www.karger.com/dee
  © 2012 S. Karger AG, Basel 
  R e s u l t s  
  Demographic and Clinical Characteristics of the Four Groups 
 The four groups were well matched for gender and education. Compared to the MCI and 
NC groups, age was significantly higher in the mild AD group (p   !   0.05). Marital status was 
significantly different between the MCI group and the SCI group (p   !   0.05). The mean 
MMSE score was lower and ADL score was greater in the mild AD group than in the other 
three groups (p   !   0.05), indicating that cognitive function and abilities of daily living were 
worst in the mild AD group. The MMSE score was lower in the MCI group than in the SCI 
and NC groups (  table 1 ).
    Frequency of NPS among the Four Groups 
  Among mild AD patients, 95.7% had at least one symptom, which was a significantly 
higher percentage than in the other three groups (p   !   0.05). In the mild AD group, the most 
c o mm o n  s ym p t o m s  w e r e  a p a th y  ( 8 7 . 0 % ) ,  irri ta b ili ty  ( 54.3 % ) ,  agi ta ti o n  ( 3 4. 8 % ) ,  anxi e ty  
(32.6%), and depression (30.4%). In the MCI group, 81.6% had at least one symptom and the 
most common symptoms were irritability (44.7%), apathy (39.5%), depression (28.9%), sleep 
disturbance (26.3%), and anxiety (26.3%). In the SCI group, 79.2% had at least one symptom 
and the most common symptoms were irritability (54.2%), apathy (33.3%), and depression 
(29.2%). When comparing the four groups, the frequency of depression was higher in the 
MCI and SCI groups than in the NC group (p   !   0.05). In the mild AD group, agitation, apa-
thy, and AMB were significantly more common than in the other three groups (p   !   0.05). 
The mild AD group also had more frequently delusion than the SCI group and more delu-
sion, depression, and anxiety than the NC group (p   !   0.05;   table 2 ).
  Concerning the clinically significant NPS, the most common symptoms were nighttime 
behaviors (10.2%), apathy/indifference (6.1%), anxiety (4.1%), and irritability/lability (4.1%) 
in the NC group, nighttime behavior (20.8%), apathy/indifference (20.8%), and depression/
dysphoria (8.3%) in the SCI group, nighttime behaviors (21.1%), apathy/indifference (18.4%), 
irritability/lability (15.8%), and anxiety (15.8%) in the MCI group, and apathy/indifference 
(80.4%), irritability/lability (30.4%), and AMB (23.9%) in the mild AD group (  fig. 1 ).  Group 
comparisons showed that there were significant differences in the frequency of delusion
(    2   = 15.21, p = 0.002), agitation (    2   = 11.14, p = 0.011), apathy (    2   = 67.52, p = 0.000), irrita-
bility/liability (   2  = 15.59, p = 0.001), and AMB (   2  = 21.71, p = 0.000) among the four groups. 
The frequency of depression/dysphoria (    2   = 6.76, p = 0.080) and anxiety (    2   = 6.39, p = 
0.094) showed a trend to differ among the four groups. Post-hoc comparisons showed that 
there was no significant difference in the frequency of clinically significant NPS between the 
Table 1.   Demographic and clinical characteristics of study participants
Characteristic Mild  AD
(n = 46)
MCI
(n = 38)
SCI
(n = 24)
NC
(n = 49)
F(2) p
Gender (male/female)  17/29 21/17 8/16 27/22 5.99 0.112
Age, years  75867 1 887 1 887 0 89 4.77 0.003
Married, % 73.9 94.7 75.0 87.8 19.57 0.026
Education, years 13851 4 831 5 831 4 83 1.63 0.186
MMSE score 23822 8 812 9 812 9 81 137.25 <0.001
D  ata are mean 8 SD unless otherwise indicated.204
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Table 2.   Prevalence (%) of NPS (NPI domain score >0) in mild AD, MCI, SCI, and NC groups
NPI domain Mild AD
(n = 46)
MCI
(n = 38)
SCI
(n = 24)
NC
(n = 49)
K-W 
test
p
p   for post-hoc comparison
SCI vs  .
NC
MCI vs. 
NC
AD vs. 
NC
MCI vs. 
SCI
AD vs. 
SCI
AD vs. 
MCI
Delusion 23.9 10.5 0 4.1 0.002 n.s. n.s. 0.01 n.s. 0.01 n.s.
Hallucination 6.5 2.6 4.2 2.0 n.s. n.s. n.s. n.s. n.s. n.s. n.s.
Agitation/aggression 34.8 13.2 8.3 12.2 0.008 n.s. n.s. 0.01 n.s. 0.02 0.02
Depression/dysphoria 30.4 28.9 29.2 8.2 0.032 0.02 0.01 0.01 n.s. n.s. n.s.
Anxiety 32.6 26.3 12.5 14.3 n.s. n.s. n.s. 0.04 n.s. n.s. n.s.
Euphoria 2.2 0 0 0 n.s. n.s. n.s. n.s. n.s. n.s. n.s.
Apathy/indifference 87.0 39.5 33.3 22.4 <0.001 n.s. n.s. <0.001 n.s. <0.001 <0.001
Disinhibition 13.0 2.6 4.2 4.1 n.s. n.s. n.s. n.s. n.s. n.s. n.s.
Irritability/lability 54.3 44.7 54.2 38.8 n.s. n.s. n.s. n.s. n.s. n.s. n.s.
AMB 28.3 5.3 0 0 <0.001 n.s. n.s. <0.001 n.s. 0.01 0.01
Nighttime behaviors 19.6 26.3 25.0 20.4 n.s. n.s. n.s. n.s. n.s. n.s. n.s.
Appetite/eating change 6.5 5.3 4.2 0 n.s. n.s. n.s. n.s. n.s. n.s. n.s.
NPI 95.7 81.6 79.2 63.3 0.001 n.s. n.s. <0.001 n.s. 0.03 0.04
K-W   test = Kruskal-Wallis test; n.s. = no significance.
  Fig. 1.   Frequency of clinically significant NPS (NPI domain score   6  4) in mild AD, MCI, SCI, and NC 
groups. 205
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SCI and NC groups (p   1   0.05). Therefore, the subjects in the SCI group were combined with 
NCs as cognitively normal. The frequency of delusion (Fisher’s exact p = 0.038) was signifi-
cantly different between the MCI and cognitively normal groups. The frequency of delusion 
(Fisher’s exact p = 0.000), agitation (Fisher’s exact p = 0.003), anxiety (Fisher’s exact p = 
0.022), apathy (    2   = 57.92, p = 0.000), irritability (    2   = 15.97, p = 0.000), and AMB (Fisher’s 
exact p = 0.000) was significantly greater in the AD group relative to cognitively normal sub-
jects. The frequency of apathy (    2   = 32.08, p = 0.000) and AMB (    2   = 5.53, p = 0.019) was 
significantly higher in the AD group compared with the MCI group.
    Clinical Correlates of NPS 
  After controlling for effects of age and education, mean scores for hallucination (partial 
correlation, r = –0.337, d.f. = 42, p = 0.025) and appetite/eating change (partial correlation,
r = –0.304, d.f. = 42, p = 0.045) were correlated with mean MMSE score in the AD group. In 
the MCI group, the mean apathy score was associated with the mean MMSE score (partial 
correlation, r = –0.379, d.f. = 34, p = 0.023). There was no significant correlation between the 
subscores of NPS and MMSE scores in the cognitively normal group. Logistic regression 
analysis showed that MMSE score (OR 6.40, 95% CI 1.76–23.28, p = 0.005) and presence of 
apathy (OR 21.82, 95% CI 1.54–309.71, p = 0.023) were significant determinants for subjects’ 
group status as cognitively normal or mild AD (Hosmer-Lemeshow test     2   = 0.935, d.f. = 8, 
p = 0.999, R  2   = 0.69, –2 log likelihood = 18.27). MMSE score (OR 4.84, 95% CI 1.92–12.16,
p = 0.001) and apathy score (OR 12.73, 95% CI 1.48–109.68, p = 0.021) also significantly de-
termined the diagnostic status as MCI or mild AD (Hosmer-Lemeshow test     2   = 1.408,
d.f. = 8, p = 0.994, R  2   = 0.65, –2 log likelihood = 26.80;   table 3  ). Stepwise linear regression 
analysis showed that MMSE score solely contributed as a determinant of group status as MCI 
or cognitively normal (Wilks’    = 0.86, F = 17.58, p = 0.000, cross-validated classification ac-
curacy = 70.3%).
  Discussion 
  This is the first study in mainland China to systematically investigate and compare the 
prevalence of NPS across the declining memory continuum in a memory clinic setting. In 
the present study, the frequency and presentation of NPS in mild AD were significantly dif-
ferent from MCI, SCI, and NC. There were 95.7% of mild AD patients who had at least one 
symptom. The most common symptoms were apathy, irritability, agitation, anxiety, and 
depression. Our findings confirm previous estimates of a high prevalence rate and a com-
mon presentation of NPS in dementia   [21, 22]  . Many studies reported that the most com-
mon NPS in patients with mild AD were apathy, depression, anxiety, and irritability   [23–
Wald p OR 95% CI
Cognitively normal vs. AD
Gender 3.70 0.055 33.34 0.93–0.001
MMSE score 7.94 0.005 6.40 1.76–23.28
Apathy score 5.19 0.023 21.82 1.54–309.71
MCI vs. AD
MMSE score 11.23 0.001 4.84 1.92–12.16
Apathy score 5.36 0.021 12.73 1.48–109.68
Table 3.   Logistic regression for 
clinical correlates of NC, MCI, 
and AD groups206
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26]  . In our study, we also found that the frequency of clinically significant NPS was high in 
mild AD. The most common clinically significant symptoms were apathy, irritability, and 
AMB. The frequencies of apathy and AMB were significantly greater than in the other three 
groups.
    The frequency of NPS in the MCI group was 81.6%. The most common symptoms were 
irritability, apathy, depression, sleep, and anxiety. The results were similar as in previous 
studies. In the Cardiovascular Health Study, 43% of MCI patients exhibited NPS, with de-
pression, apathy, and irritability being the most common symptoms   [4]  . Hwang et al.   [27] 
  found that the most common symptoms in MCI were depression, apathy, irritability, and 
anxiety. Rozzini et al.  [28]  also found that about 85% of MCI patients had some NPS, and the 
most prevalent symptom was depression, followed by anxiety. In a review by Monastero et 
al.   [9]  , the global prevalence of NPS in MCI ranged from 35 to 85%, the most common be-
havioral symptoms were depression, anxiety, and irritability, and hospital-based samples 
reported a higher global prevalence of NPS than population-based studies. Our study also 
found that the most common clinically significant symptoms were sleep and apathy in the 
MCI group. Although NPS were common in the MCI group, clinically significant NPS were 
relatively rare.
    SCI was common in aged persons: about 22–50% of   1  65-year-old persons reported SCI 
in the community   [10, 11, 29]  . But there has been little research on NPS associated with SCI. 
In the present study, 79.2% of the SCI group had at least one symptom. The most common 
symptoms were irritability, apathy, and depression. In the SCI group, the most common 
clinically significant symptoms were sleep and apathy. Clinically significant NPS were rela-
tively rare in the SCI group.
  The frequency of NPS, in particular agitation, apathy, and AMB, was significantly great-
er among mild AD patients than in the other three groups. Clinically significant symptoms, 
such as apathy and AMB, were also more common in mild AD than in MCI, SCI, and NC. 
There were significant associations between cerebral white-matter changes and apathy   [30]  . 
Brain white-matter hyperintensities were associated with symptoms of AMB  [31] . It was sug-
gested that brain structure changes may be associated with the presence of NPS in AD. In 
the stage of mild AD, the brain structure might have changed so that the NPS in mild AD 
were different from MCI, SCI, and NC.
    In the present study, the frequency of depression was greater in MCI and SCI than in 
NC. Modrego et al.   [32]   found that patients with MCI and depression had more than twice 
the risk of developing AD than those without depression. Gabryelewicz et al.   [33]   observed 
that the occurrence of depressive symptoms might constitute a predictor for those who are 
more likely to progress to dementia. According to Teng et al.   [34]  ,     depression and apathy ap-
pear to be the most useful symptoms to identify MCI subjects at a higher risk of developing 
dementia. Subjects with MCI might have neuropathological changes of AD, and the abnor-
malities were most severe in the limbic system  [35, 36] . Thus, the mood disturbances in MCI 
might reflect the pathologic and neurochemical changes of the limbic system.
    We found that apathy may be useful in identifying individuals with mild AD and dis-
tinguishing mild AD from MCI. Apathy has been found to discriminate between subjects 
with normal cognition and subjects with MCI in a Chinese community   [37]  . The finding is 
of great clinical significance. In Chinese culture, caregivers may not easily identify apathy as 
it is less likely to cause destructive behavior   [38]  . To better identify individuals with suspect-
ed dementia, clinicians should be trained to recognize NPS, in particular apathy, in the clin-
ical practice.
    There are several limitations of this study. The subjects were referred from a memory 
clinic setting; therefore, the sample may not be representative of community samples of in-
dividuals with mild AD, MCI, and SCI. Furthermore, the assessment was cross-sectional and 207
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was unable to examine the causal link between the clinical correlates and NPS. Thus, longi-
tudinal follow-up studies are required to delineate these relationships.
    In summary, across the declining memory continuum, the frequency of NPS was the 
highest among mild AD patients. The NPS in AD were significantly different from those in 
MCI, SCI, and NC. NPS were prevalent among individuals with SCI and MCI, though with-
out reaching clinical significance. The symptoms of depression, apathy, and AMB deserve 
more attention in the declining memory continuum. Apathy might be a predictor of the pro-
gression from cognitively normal to MCI and eventually to AD.
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